Rare diseases
Investigational molecules
Locations
Back to Spain1 052 clinical trials in Malaga, Spain across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Study of Acalabrutinib with R-CHOP for Patients with Untreated Mantle Cell Lymphoma in Spain
SpainSpainStudy on Cetuximab and Drug Combination for Patients with Metastatic Colorectal Cancer
SpainStudy Comparing Nivolumab and Relatlimab with Chemotherapy to Pembrolizumab with Chemotherapy for Advanced Non-Small Cell Lung Cancer Patients
SpainStudy on the Safety and Effectiveness of Volrustomig with FOLFIRI and Bevacizumab for Colorectal Cancer Patients Without Liver Metastases
SpainStudy of Adagrasib with Pembrolizumab and Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation
SpainLong-Term Safety Study of Inhaled Pirfenidone for Patients with Progressive or Idiopathic Pulmonary Fibrosis
SpainStudy of Omecamtiv Mecarbil for Treating Patients with Chronic Heart Failure and Severely Reduced Heart Pumping Ability
SpainStudy comparing NVL-655 to alectinib in untreated patients with ALK-positive advanced non-small cell lung cancer
SpainStudy Comparing Oral Azacitidine and Cedazuridine with Subcutaneous Azacitidine for Patients with Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
SpainStudy Comparing Sacituzumab Govitecan and Standard Treatment for Patients with Previously Treated Extensive Stage Small Cell Lung Cancer
SpainStudy on ITI-1284 for Treating Agitation in Alzheimer's Patients
SpainThe busiest research cities in the country
What the registry says about research in the country
Research focusing on innovative treatments for cutaneous lupus erythematosus and myasthenia gravis, evaluating new therapeutic approaches to improve patient outcomes.
Studies aim to assess novel therapies' effectiveness in reducing disease activity and improving daily living activities.
Innovative vaccine development studies targeting COVID-19, cytomegalovirus, and respiratory syncytial virus, focusing on prevention and immune response.
Research emphasizes safety and immunogenicity in various population groups.
Advanced studies in bladder cancer, colorectal cancer, and gastric cancer, evaluating targeted therapies and combination treatments.
Trials focus on improving survival rates and treatment responses in various cancer types.
Research examining new treatments for chronic rhinosinusitis and COPD, with emphasis on symptom management and exacerbation prevention.
Studies evaluate novel therapeutic approaches for chronic respiratory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
